CoChat

CO-OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW: Anxiety in Bipolar Disorder

Vázquez, Gustavo H., Baldessarini, Ross J., Tondo, Leonardo · 2014 · Depression and Anxiety
Cited by 93

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Anxiety commonly co-occurs with bipolar disorders (BDs), but the significance of such "co-morbidity" remains to be clarified and its optimal treatment adequately defined. METHODS: We reviewed epidemiological, clinical, and treatment studies of the co-occurrence of BD and anxiety disorder through electronic searching of Pubmed/MEDLINE and EMBASE databases. RESULTS: Nearly half of BD patients meet diagnostic criteria for an anxiety disorder at some time, and anxiety is associated with poor treatment responses, substance abuse, and disability. Reported rates of specific anxiety disorders with BD rank: panic ≥ phobias ≥ generalized anxiety ≥ posttraumatic stress ≥ obsessive-compulsive disorders. Their prevalence appears to be greater among women than men, but similar in types I and II BD. Anxiety may be more likely in depressive phases of BD, but relationships of anxiety phenomena to particular phases of BD, and their temporal distributions require clarification. Adequate treatment trials for anxiety syndromes in BD patients remain rare, and the impact on anxiety of treatments aimed at mood stabilization is not clear. Benzodiazepines are sometimes given empirically; antidepressants are employed cautiously to limit risks of mood switching and emotional destabilization; lamotrigine, valproate, and second-generation antipsychotics may be useful and relatively safe. CONCLUSIONS: Anxiety symptoms and syndromes co-occur commonly in patients with BD, but "co-morbid" phenomena may be part of the BD phenotype rather than separate illnesses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/da.22248

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 111

  1. Goodwin, 2007, Manic-Depressive Illness
  2. Baldessarini, 2010, Bipolar depression: overview and commentary, Harv Rev Psychiatry, 18, 143, 10.3109/10673221003747955 · DOI · Paper page
  3. Tondo, 2003, Suicidal behaviour in bipolar disorder: risk and prevention, CNS Drugs, 17, 491, 10.2165/00023210-200317070-00003 · DOI · Paper page
  4. Strakowski, 1998, Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after first psychiatric hospitalization, J Clin Psychiatry, 59, 465, 10.4088/JCP.v59n0905 · DOI · Paper page
  5. Kupfer, 2005, Increasing medical burden in bipolar disorder, JAMA, 293, 2528, 10.1001/jama.293.20.2528 · DOI · Paper page
  6. Fortin, 2007, Multimorbidity's many challenges, BMJ, 334, 1016, 10.1136/bmj.39201.463819.2C · DOI · Paper page
  7. Valderas, 2009, Defining comorbidity: implications for understanding health and health services, Ann Fam Med, 7, 357, 10.1370/afm.983 · DOI · Paper page
  8. Winokur, 1990, The concept of secondary depression and its relationship to comorbidity, Psychiatr Clin North Am, 13, 567, 10.1016/S0193-953X(18)30336-8 · DOI
  9. Praag, 1996, Comorbidity (psycho)analysed, Br J Psychiatry, 168, 129s, 10.1192/S0007125000298516 · DOI
  10. Wittchen, 1996, Critical issues in the evaluation of comorbidity of psychiatric disorders, Br J Psychiatry, 168, 9s, 10.1192/S000712500029836X · DOI · Paper page
  11. Praag, 1999, Impact psychopharmacology and biological psychiatry, Dialog Clin Neurosci, 1, 141, 10.31887/DCNS.1999.1.3/hmvanpraag · DOI
  12. Zimmerman, 1999, Psychiatric diagnosis in clinical practice: is comorbidity being missed, Compr Psychiatry, 40, 182, 10.1016/S0010-440X(99)90001-9 · DOI · Paper page
  13. American Psychiatric Association (APA), 1980, Diagnostic and Statistical Manual of Mental Disorders, editions 3 to 5 (DSM-III, DSM-III-R, DSM-IV, DSM-IV-TR, DSM-5)
  14. World Health Organization (WHO), 2014, International Statistical Classification of Diseases and Related Health Problems, eleventh edition (ICD-11)
  15. Yatham, 2013, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder, Bipolar Disord, 15, 1, 10.1111/bdi.12025 · DOI · Paper page
  16. Vázquez, 2013, Overview of antidepressant treatment in bipolar depression: critical commentary, Intl J Neuropsychopharmacol, 22, 1
  17. Baldessarini, 2013, Rate of new-onset mania or hypomania in patients diagnosed with unipolar major depression, J Affect Disord, 148, 129, 10.1016/j.jad.2012.10.033 · DOI · Paper page
  18. Goikolea, 2013, Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics vs. haloperidol, J Affect Disord, 144, 191, 10.1016/j.jad.2012.07.038 · DOI
  19. Provencher, 2012, Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue?, J Affect Disord, 137, 161, 10.1016/j.jad.2011.12.001 · DOI
  20. Chen, 1995, Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders, Psychiatry Res, 59, 57, 10.1016/0165-1781(95)02752-1 · DOI · Paper page
  21. Pini, 1997, Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia, J Affect Disord, 42, 145, 10.1016/S0165-0327(96)01405-X · DOI · Paper page
  22. Rihmer, 2001, Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary, J Affect Disord, 67, 175, 10.1016/S0165-0327(01)00309-3 · DOI
  23. Simon, 2003, Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression, J Psychiatr Res, 37, 187, 10.1016/S0022-3956(03)00021-9 · DOI
  24. Zimmermann, 2009, Heterogeneity of DSM-IV major depressive disorder as a consequence of sub-threshold bipolarity, Arch Gen Psychiatry, 66, 1341, 10.1001/archgenpsychiatry.2009.158 · DOI · Paper page
  25. Angst, 1998, Emerging epidemiology of hypomania and bipolar II disorder, J Affect Disord, 50, 143, 10.1016/S0165-0327(98)00142-6 · DOI · Paper page
  26. Chen, 1995, Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiology Catchment Area survey, Am J Psychiatry, 152, 280, 10.1176/ajp.152.2.280 · DOI · Paper page
  27. Kessler, 1997, Epidemiology of DSM-III-R bipolar I disorder in a general population survey, Psychol Med, 27, 1079, 10.1017/S0033291797005333 · DOI · Paper page
  28. Goodwin, 2002, Bipolar-panic comorbidity in the general population: prevalence and associated morbidity, J Affect Disord, 70, 27, 10.1016/S0165-0327(01)00398-6 · DOI
  29. Sala, 2012, Course of comorbid anxiety disorders among adults with bipolar disorder in the US population, J Psychiatr Res, 46, 865, 10.1016/j.jpsychires.2012.03.024 · DOI · Paper page
  30. McElroy, 2001, Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder, Am J Psychiatry, 158, 420, 10.1176/appi.ajp.158.3.420 · DOI · Paper page
  31. Henry, 2003, Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer, J Clin Psychiatry, 64, 331, 10.4088/JCP.v64n0316 · DOI · Paper page
  32. Simon, 2004, Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD), Am J Psychiatry, 161, 2222, 10.1176/appi.ajp.161.12.2222 · DOI · Paper page
  33. Kessler, 2005, Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication, Psychol Med, 35, 1073, 10.1017/S0033291705004538 · DOI · Paper page
  34. Kessler, 2005, Prevalence severity and comorbidity of 12 month DSM-IV disorders in the National Comorbidity Survey Replication, Arch Gen Psychiatry, 62, 617, 10.1001/archpsyc.62.6.617 · DOI · Paper page
  35. Kauer-Sant’Anna, 2009, Epidemiology and management of anxiety in patients with bipolar disorder, CNS Drugs, 23, 953, 10.2165/11310850-000000000-00000 · DOI
  36. Angst, 2011, Prevalence and characteristics of undiagnosed bipolar disorder in patients with major depressive episode, Arch Gen Psychiatry, 68, 791, 10.1001/archgenpsychiatry.2011.87 · DOI · Paper page
  37. Tsuang, 2002, Textbook in Psychiatric Epidemiology, 407, 10.1002/0471234311 · DOI · Paper page
  38. Keck, 1995, Outcome and comorbidity in first- compared with multiple-episode mania, J Nerv Ment Dis, 183, 320, 10.1097/00005053-199505000-00008 · DOI
  39. Krüger, 1995, Comorbidity of obsessive compulsive disorder in bipolar disorder, J Affect Disord, 34, 117, 10.1016/0165-0327(95)00008-B · DOI
  40. Dilsaver, 1997, Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania, Psychiatry Res, 73, 47, 10.1016/S0165-1781(97)00109-1 · DOI · Paper page
  41. Szádóczky, 1998, Prevalence of major depressive and bipolar disorders in Hungary: results from a National Epidemiologic Survey, J Affect Disord, 50, 153, 10.1016/S0165-0327(98)00056-1 · DOI · Paper page
  42. Baldassano, 2005, Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants, Bipolar Disord, 7, 465, 10.1111/j.1399-5618.2005.00237.x · DOI · Paper page
  43. Faravelli, 2006, Threshold and subthreshold bipolar disorders in the Sesta Fiorentino Study, J Affect Disord, 94, 111, 10.1016/j.jad.2006.01.031 · DOI
  44. Mantere, 2006, Differences in Axis I and II comorbidity between bipolar I and II disorders and major depressive disorder, J Clin Psychiatry, 67, 584, 10.4088/JCP.v67n0409 · DOI · Paper page
  45. Benedetti, 2007, Gender differences in bipolar disorder type I: 48 week prospective follow-up of 72 patients treated in an Italian tertiary care center, J Nerv Ment Dis, 195, 93, 10.1097/01.nmd.0000243781.67035.b1 · DOI
  46. Brieger, 2007, Dimensions underlying outcome criteria in bipolar I disorder, J Affect Disord, 99, 1, 10.1016/j.jad.2006.08.012 · DOI
  47. Albert, 2008, Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes, J Affect Disord, 105, 297, 10.1016/j.jad.2007.05.020 · DOI
  48. Altshuler, 2010, Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network, Am J Psychiatry, 167, 708, 10.1176/appi.ajp.2009.09010105 · DOI · Paper page
  49. Saunders, 2012, Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women, Depress Anxiety, 29, 739, 10.1002/da.21932 · DOI · Paper page
  50. Das, 2013, Anxiety disorders in bipolar I mania: prevalence, effect on illness severity, and treatment implications, Indian J Psychol Med, 35, 53, 10.4103/0253-7176.112202 · DOI
  51. Baldessarini, 2013, First-episode types in bipolar disorder: predictive associations with later illness, Acta Psychiatr Scand, 127, 355
  52. Fogarty, 1994, Epidemiology of psychiatric disorders in Edmonton, Acta Psychiatr Scand Suppl, 376, 16, 10.1111/j.1600-0447.1994.tb05787.x · DOI
  53. Salvatore, 2013, Antecedents of manic vs. other first psychotic episodes in 263 bipolar I disorder patients, Acta Psychiatr Scand, 10.1111/acps.12170 · DOI · Paper page
  54. Salvatore, 2013, Negative affective features in 516 cases of first psychotic disorder episodes: relationship to suicidal risk, J Depress Anxiety, 10.4172/2167-1044.1000131 · DOI
  55. Freeman, 2002, The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues, J Affect Disord, 68, 1, 10.1016/S0165-0327(00)00299-8 · DOI · Paper page
  56. McIntyre, 2007, Medical comorbidity in bipolar disorder: re-prioritizing unmet needs, Curr Opin Psychiatry, 20, 406, 10.1097/YCO.0b013e3281938102 · DOI · Paper page
  57. Mantere, 2010, Prospective latent analyses study of psychiatric comorbidity of DSM-IV bipolar I and II disorders, Bipolar Disord, 12, 271, 10.1111/j.1399-5618.2010.00810.x · DOI · Paper page
  58. Coryell, 2009, Anxiety and outcome in bipolar disorder, Am J Psychiatry, 166, 1238, 10.1176/appi.ajp.2009.09020218 · DOI · Paper page
  59. Parker, 2010, Comorbidities in bipolar disorder: models and management, Med J Austral, 193, s18
  60. Cazard, 2013, [Bipolar disorders and comorbid anxiety: prognostic impact and therapeutic challenges (French)], Encephale, 39, 66, 10.1016/j.encep.2012.04.005 · DOI
  61. Judd, 2003, Prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account sub-threshold cases, J Affect Disord, 73, 123, 10.1016/S0165-0327(02)00332-4 · DOI · Paper page
  62. Dickstein, 2005, Comorbid anxiety in phenotypes of pediatric bipolar disorder, J Child Adolesc Psychopharmacol, 15, 534, 10.1089/cap.2005.15.534 · DOI · Paper page
  63. Gaudiano, 2005, Anxiety disorder comorbidity in bipolar I disorder: relationship to depression severity and treatment outcome, Depress Anxiety, 21, 71, 10.1002/da.20053 · DOI · Paper page
  64. Keck, 2008, Clinical and economic effects of unrecognized or inadequately treated bipolar disorder, J Psychiatr Pract, 14, 31, 10.1097/01.pra.0000320124.91799.2a · DOI · Paper page
  65. Gao, 2010, Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders, Am J Addict, 19, 440, 10.1111/j.1521-0391.2010.00060.x · DOI · Paper page
  66. Hawke, 2013, Bipolar disorder with comorbid anxiety disorders: impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation, Int J Bipolar Disord, 1, 15, 10.1186/2194-7511-1-15 · DOI
  67. MacKinnon, 2003, Rapid switching of mood in families with multiple cases of bipolar disorder, Arch Gen Psychiatry, 60, 921, 10.1001/archpsyc.60.9.921 · DOI · Paper page
  68. Simon, 2007, Risk of suicide attempt and suicide death in patients treated for bipolar disorder I, Bipolar Disord, 9, 526, 10.1111/j.1399-5618.2007.00408.x · DOI · Paper page
  69. Goldstein, 2012, Predictors of prospectively examined suicide attempts among youth with bipolar disorder, Arch Gen Psychiatry, 69, 1113, 10.1001/archgenpsychiatry.2012.650 · DOI · Paper page
  70. Angst, 2005, Suicide in 406 mood-disorder patients with and without long-term medication: 40 to 44 year follow-up, Arch Suicide Res, 9, 279, 10.1080/13811110590929488 · DOI · Paper page
  71. Schaffer, 2012, CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders, Ann Clin Psychiatry, 24, 6
  72. Perugi, 2002, Obsessive-compulsive-bipolar comorbidity: systematic exploration of clinical features and treatment outcome, J Clin Psychiatry, 63, 1129, 10.4088/JCP.v63n1207 · DOI · Paper page
  73. Uguz, 2010, Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder, Gen Hosp Psychiatry, 32, 556, 10.1016/j.genhosppsych.2010.07.004 · DOI
  74. Winkler, 2003, Clonazepam in the long-term treatment of patients with unipolar depression, bipolar or schizoaffective disorder, Eur Neuropsychopharmacol, 13, 129, 10.1016/S0924-977X(02)00174-8 · DOI
  75. Sachs, 1990, Use of clonazepam for bipolar affective disorder, J Clin Psychiatry, 51, 31
  76. Perugi, 2010, Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: 3-year “open” follow-up study, Eur Arch Psychiatry Clin Neurosci, 260, 553, 10.1007/s00406-010-0109-y · DOI
  77. Tohen, 2007, Effect of comorbid anxiety on treatment response in bipolar depression, J Affect Disord, 104, 137, 10.1016/j.jad.2007.03.014 · DOI · Paper page
  78. Provencher, 2011, Psychotherapies for comorbid anxiety in bipolar spectrum disorders, J Affect Disord, 133, 371, 10.1016/j.jad.2010.10.040 · DOI
  79. Morishita, 2009, Clonazepam as a therapeutic adjunct to improve management of depression: brief review, Hum Psychopharmacol, 24, 191, 10.1002/hup.1015 · DOI · Paper page
  80. Vázquez, 2014, Pharmacological treatment for bipolar depression, Adv Psychiatr Treatment, 10.1192/apt.bp.113.011460 · DOI
  81. Gao, 2010, Comorbid anxiety and substance use disorders associated with a lower use of mood-stabilizers in patients with rapid-cycling bipolar disorder: descriptive analysis of cross-sectional data of 566 patients, Int J Clin Pract, 64, 336, 10.1111/j.1742-1241.2009.02284.x · DOI
  82. Fava, 2001, Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis, J Clin Psychiatry, 62, 556, 10.4088/JCP.v62n07a10 · DOI · Paper page
  83. Lam, 2003, Randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year, Arch Gen Psychiatry, 60, 145, 10.1001/archpsyc.60.2.145 · DOI · Paper page
  84. Singh, 2006, Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials, Bipolar Disord, 8, 696, 10.1111/j.1399-5618.2006.00371.x · DOI · Paper page
  85. McDougle, 1991, Controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy, J Clin Psychopharmacol, 11, 175, 10.1097/00004714-199106000-00005 · DOI · Paper page
  86. Pigott, 1991, Controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder, J Clin Psychopharmacol, 11, 242, 10.1097/00004714-199108000-00004 · DOI · Paper page
  87. Uhde, 1988, Lack of efficacy of carbamazepine in the treatment of panic disorder, Am J Psychiatry, 145, 1104, 10.1176/ajp.145.9.1104 · DOI · Paper page
  88. Hertzberg, 1999, Preliminary study of lamotrigine for the treatment of posttraumatic stress disorder, Biol Psychiatry, 45, 1226, 10.1016/S0006-3223(99)00011-6 · DOI · Paper page
  89. Ameringen, 2004, Antiepileptic drugs in the treatment of anxiety disorders: role in therapy, Drugs, 64, 2199, 10.2165/00003495-200464190-00004 · DOI
  90. Keck, 2006, Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders, J Clin Psychiatry, 67, 8
  91. Mula, 2007, Role of anticonvulsant drugs in anxiety disorders: critical review of the evidence, J Clin Psychopharmacol, 27, 263, 10.1097/jcp.0b013e318059361a · DOI · Paper page
  92. Pande, 1999, Treatment of social phobia with gabapentin: placebo-controlled study, J Clin Psychopharmacol, 19, 341, 10.1097/00004714-199908000-00010 · DOI · Paper page
  93. Pande, 2000, Placebo-controlled study of gabapentin treatment of panic disorder, J Clin Psychopharmacol, 20, 467, 10.1097/00004714-200008000-00011 · DOI · Paper page
  94. Strawn, 2007, Treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic, Neuropsychiatr Dis Treat, 3, 237, 10.2147/nedt.2007.3.2.237 · DOI
  95. Bowden, 2007, Spectrum of effectiveness of valproate in neuropsychiatry, Expert Rev Neurother, 7, 9, 10.1586/14737175.7.1.9 · DOI
  96. Aliyev, 2008, Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study, Eur Psychiatry, 23, 109, 10.1016/j.eurpsy.2007.08.001 · DOI · Paper page
  97. Vulink, 2011, Review of atypical antipsychotics in anxiety, Eur Neuropsychopharmacol, 21, 429, 10.1016/j.euroneuro.2010.12.007 · DOI
  98. Reich, 2004, Preliminary study of risperidone in the treaetment of post-traumatic stress dusirder related to childhood abuse in women, J Clin Psychiatry, 65, 1601, 10.4088/JCP.v65n1204 · DOI · Paper page
  99. Bartzokis, 2005, Adjunctive risperidone in the treatment of chronic combat-related post-traumatic stress disorder, Biol Psychiatry, 57, 474, 10.1016/j.biopsych.2004.11.039 · DOI · Paper page
  100. Shapira, 2004, Double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder, Biol Psychiatry, 55, 553, 10.1016/j.biopsych.2003.11.010 · DOI
  101. Butterfield, 2001, Olanzapine in the treatment of post-traumatic stress disorder: pilot study, Int Clin Psychopharmacol, 16, 197, 10.1097/00004850-200107000-00003 · DOI · Paper page
  102. Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: double-blind, placebo-controlled study, Am J Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page
  103. Katzman, 2011, Aripiprazole: clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness, J Affect Disord, 128, S11, 10.1016/S0165-0327(11)70004-0 · DOI
  104. Kessler, 2003, Epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication, JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
  105. Altmaca, 2002, Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: single-blind, placebo-controlled study, Int Clin Psychopharmacol, 17, 115, 10.1097/00004850-200205000-00004 · DOI · Paper page
  106. Gao, 2009, Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders, Expert Rev Neurother, 9, 1147, 10.1586/ern.09.37 · DOI · Paper page
  107. Zarate, 2008, Riluzole in psychiatry: systematic review of the literature, Expert Opin Drug Metab Toxicol, 4, 1223, 10.1517/17425255.4.9.1223 · DOI · Paper page
  108. Papolos, 2013, Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype, J Affect Disord, 147, 431, 10.1016/j.jad.2012.08.040 · DOI
  109. Prasko, 2007, Effect of repetitive transcranial magnetic stimulation (rTMS) added on to serotonin reuptake inhibitors in patients with panic disorder: randomize, double-blind, sham-controlled study, Neuro Endocrinol Lett, 1, 33
  110. George, 2009, Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treatment psychiatric diseases (depression, mania, schizophrenia, obsessive-compulsive disorder, panic, posttraumatic stress disorder), Brain Stimul, 2, 14, 10.1016/j.brs.2008.06.001 · DOI · Paper page
  111. Paes, 2011, Value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: integrative review, CNS Neurol Disord Drug Targets, 10, 610, 10.2174/187152711796234943 · DOI · Paper page

Cited by

See all 93

Metadata

Authors
Vázquez, G. H., Baldessarini, R. J., & Tondo, L.
Venue
Depression and Anxiety
Published
2014-03
Volume
31
Issue
3
Pages
196-206
ISSN
1091-4269 (ISSN-L)
OpenAlex
W1576109028
Cited by
93
References
40
FWCI
8.09
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 549 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CO-OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW: Anxiety in Bipolar Disorder. https://app.cochat.ai/papers/10.1002/da.22248
The paper
Vázquez, G. H., Baldessarini, R. J., & Tondo, L. (2014). CO-OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW: Anxiety in Bipolar Disorder. Depression and Anxiety. https://doi.org/10.1002/da.22248

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.